Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
WonderFi Announces Approval to List the Warrants Issued in Connection with Its Previously Closed $26.4 Million Bought Deal Private Placement
-
Tricon Residential inc. (TCN) PT Raised to $17 at Canaccord Genuity
-
Canaccord Genuity Upgrades Hexo Corp. (HEXO:CN) (HEXO) to Spec. Buy
-
Canaccord Genuity Downgrades Argonaut Gold (AR:CN) (ARNGF) to Hold
-
Goodbody Health Announces Normal Course Issuer Bid and Restricted Share Unit Plan
-
Form 8.3 - [Clinigen Group plc - 03 03 2022] - (CGWL)
-
UPDATE: Canaccord Genuity Upgrades AeroVironment (AVAV) to Buy
-
UPDATE: Canaccord Genuity Upgrades Tilray (TLRY) to Buy
-
Thor Exploration Ltd: Director Dealing
-
Nevada Silver Corporation Announces $7 Million Brokered Private Placement
-
Canaccord Genuity Upgrades Q4 Inc. (QFOR:CN) to Spec. Buy
-
Tilray, Inc. (TLRY) Announces Proposed Agreement for Strategic Alliance With Hexo Corp. (HEXO)
-
Lifetime Brands (LCUT) Acquires S’well
-
Bitfarms to Present at Upcoming Investor Conferences
-
Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.
-
Lifetime Brands Acquires S’well®
-
HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders
-
Bitfarms to Present at Upcoming Investor Conferences
-
HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders
-
Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.
-
Form 8.3 - [Clinigen Group plc - 02 03 2022] - (CGWL)
-
Aytu BioScience (AYTU) Prices 3.03M Share and Warrant Offering at $1.25/sh
-
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering
-
Northern Graphite Financing Update
-
Canaccord Genuity Downgrades Appen Ltd. (APX:AU) (APPEF) to Hold
-
Canaccord Genuity Downgrades Lowell Farms (LOWL:CN) (LOWLF) to Hold
-
UPDATE: Canaccord Genuity Upgrades Inseego Corp. (INSG) to Buy
-
Blue Apron to Present at Upcoming Investor Conferences
-
Nanox to Present at Two Upcoming Investor Conferences in March 2022
-
Form 8.3 - [Clinigen Group plc - 28 02 2022] - (CGWL)
-
AYURCANN HOLDINGS CORP. ANNOUNCES BUYBACK OF COMMON SHARES UNDER NORMAL COURSE ISSUER BID
-
Proactive news headlines including Suvo Strategic Minerals, Lake Resources, Queensland Pacific Metals and KGL Resources
-
Proactive news headlines including Suvo Strategic Minerals, Lake Resources, Queensland Pacific Metals and KGL Resources
-
Liquid Meta Announces Participation in Upcoming Investor Events
-
Zedcor Inc. Announces Proposed Public Offering of Units and Conversion of Series 1 Preferred Shares
-
Sustainable Real Estate Dividend Fund Files Final Prospectus
-
PharmaCann and LivWell Enlightened Health Announce Completion of Merger
-
Form 8.3 - [Clinigen Group plc - 25 02 2022] - (CGWL)
-
Biogen (BIIB) PT Lowered to $285 at Canaccord Genuity
-
Form 8.3 - [Clinigen Group plc - 24 02 2022] - (CGWL)
-
Source Rock Royalties Files Final Prospectus for Upsized Initial Public Offering
-
NanoXplore Inc. Announces Closing of $30 Million Bought Deal Public Offering
-
Canaccord Genuity Upgrades Definitive Healthcare Corp (DH) to Buy
-
Baroyeca Gold & Silver Inc. Announces Private Placement Financing Closed and Investor Relations Contract
-
SoftBank-backed Gousto in $230 million secondary placing
-
Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock
-
Mogo to Participate in the Canaccord Genuity Digital Disruptor Conference
-
Nevada Vanadium Engages Canaccord and Announces Private Placement for Gross Proceeds of up to $4,000,000
-
Panbela Therapeutics Inc. (PBLA) Acquires Cancer Prevention Pharmaceuticals
-
Panbela Therapeutics Inc. (PBLA) to Acquire Cancer Prevention Pharmaceuticals


